![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/04 | |
C07K 7/08 |
(11) | Number of the document | 2790715 |
(13) | Kind of document | T |
(96) | European patent application number | 11817532.2 |
Date of filing the European patent application | 2011-12-13 | |
(97) | Date of publication of the European application | 2014-10-22 |
(45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2011/003256 |
Date | 2011-12-13 |
(87) | Number | WO 2013/088194 |
Date | 2013-06-20 |
(72) |
MULLER, Sylviane, FR
BRIAND, Jean-Paul, FR
ZIMMER, Robert, FR
|
(73) |
Centre National de la Recherche Scientifique,
3, rue Michel Ange, 75794 Paris Cedex 16,
FR
ImmuPharma France SA, 5, rue du Rhōne, 68100 Mulhouse, FR |
(54) | MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES |
MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES |